cystic fibrosis

Incidence and clinical impact of respiratory viruses in adults with cystic fibrosis
William G Flight, Rowland J Bright-Thomas, Peter Tilston, Kenneth J Mutton, Malcolm Guiver, Julie Morris, A Kevin Webb, Andrew M Jones

Thorax Mar 2014, 69 (3) 247-253; DOI: 10.1136/thoraxjnl-2013-204000
Does extensive genotyping and nasal potential difference testing clarify the diagnosis of cystic fibrosis among patients with single-organ manifestations of cystic fibrosis?
Chee Y Ooi, Annie Dupuis, Lynda Ellis, Keith Jarvi, Sheelagh Martin, Peter N Ray, Leslie Steele, Paul Kortan, Tanja Gonska, Ruslan Dorfman, Melinda Solomon, Julian Zielenski, Mary Corey, Elizabeth Tullis, Peter Durie

Thorax Mar 2014, 69 (3) 254-260; DOI: 10.1136/thoraxjnl-2013-203832
International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety
Alexandra L Quittner, Janice Abbott, Anna M Georgiopoulos, Lutz Goldbeck, Beth Smith, Sarah E Hempstead, Bruce Marshall, Kathryn A Sabadosa, Stuart Elborn

Thorax Jan 2016, 71 (1) 26-34; DOI: 10.1136/thoraxjnl-2015-207488
Clinical presentation of exclusive cystic fibrosis lung disease
Inez Bronsveld, Jan Bijman, Frauke Mekus, Manfred Ballmann, Henk J Veeze, Burkhard Tümmler

Thorax Mar 1999, 54 (3) 278-281; DOI: 10.1136/thx.54.3.278
Airway surface liquid homeostasis in cystic fibrosis: pathophysiology and therapeutic targets
Iram J Haq, Michael A Gray, James P Garnett, Christopher Ward, Malcolm Brodlie

Thorax Mar 2016, 71 (3) 284-287; DOI: 10.1136/thoraxjnl-2015-207588
Totally implantable venous access devices in children with cystic fibrosis: incidence and type of complications
J Deerojanawong, S M Sawyer, A M Fink, K B Stokes, C F Robertson

Thorax Apr 1998, 53 (4) 285-289; DOI: 10.1136/thx.53.4.285
FEV₁ decline in cystic fibrosis
Martin Miller

Thorax Mar 2013, 68 (3) 294; DOI: 10.1136/thoraxjnl-2012-202838
Author's response: understanding the natural progression in %FEV₁ decline in patients with cystic fibrosis: a longitudinal study
David Taylor-Robinson, Margaret Whitehead, Finn Diderichsen, Hanne Vebert Olesen, Tania Pressler, Rosalind Smyth, Peter Diggle

Thorax Mar 2013, 68 (3) 294-295; DOI: 10.1136/thoraxjnl-2012-202954
Exploring the challenges of accessing medication for patients with cystic fibrosis
Sophie Herbert, Nicola Jane Rowbotham, Sherie Smith, Patrick Wilson, Zoe C Elliott, Paul A Leighton, Alistair Duff, Alan Robert Smyth

Thorax Mar 2022, 77 (3) 295-297; DOI: 10.1136/thoraxjnl-2021-217140
Treatment decisions for MRSA in patients with cystic fibrosis (CF): when is enough, enough?
Scott C Bell, Patrick A Flume

Thorax Apr 2017, 72 (4) 297-299; DOI: 10.1136/thoraxjnl-2016-209605

Main menu

cystic fibrosis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

cystic fibrosis

Pages